Dengue
- Business Wire
Potential Impact of Takeda’s Dengue Vaccine Candidate Reinforced by Long-Term Safety and Efficacy Results
− Takeda’s dengue vaccine candidate (TAK-003) prevented 83.6% of hospitalizations and 62.0% of dengue illness overall, with no identified important…
Read More » - World
U.S. Food & Drug Administration Grants Priority Review of Maribavir for the Treatment of Post-Transplant Recipients With Cytomegalovirus Infection in Those Resistant and/or Refractory to Prior Anti-CMV Treat
Osaka, Japan: − If Approved, Maribavir Will Be the First and Only Treatment Indicated for Post-Transplant Cytomegalovirus (CMV) Infection in…
Read More » - Health
Takeda and IDT Support Manufacturing of Johnson & Johnson’s COVID-19 Vaccine
Osaka, Japan: Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced a mutual agreement with IDT Biologika GmbH (“IDT”), a contract development and…
Read More » - AUTO
Hyundai Motor India Foundation Commences Mobile Medical Unit – Mobile Chikitsa in Rajasthan
New Delhi, Delhi, India: ‘Sparsh Sanjeevani’ – A public health initiative by HMIF to strengthen Government of India’s Ayushman Bharat…
Read More » - COVID-19
India crosses a New Landmark in Testing
India has demonstrated an exponential increase in the number of COVID-19 cumulative tests since Jan 2020. It has crossed the…
Read More » - India
PM launches High Throughput COVID testing facilities at Kolkata, Mumbai and Noida
Prime Minister Shri Narendra Modi launched three high throughput COVID-19 testing facilities via video conferencing today. These facilities are located…
Read More » - Prime Minister's Office
PM to launch High Throughput COVID-19 testing facilities on 27 July
Prime Minister Shri Narendra Modi will launch high throughput COVID-19 testing facilities on 27th July via video conferencing. These facilities…
Read More »